Neuralink is a company developing ultra-high bandwidth brain-machine interfaces to connect humans and computers. Its primary objective is to help people with paralysis to gain more autonomy in their everyday lives, with the possibility that its tech will be used to enhance the abilities of the wider community further in the future.
For many, brain implants such as those being developed by Neuralink belong firmly in the realm of sci-fi. That said, the idea of interfacing machines with the brain for medical purposes has existed for some time, with examples including cochlear implants and Deep Brain Stimulation. Having secured FDA approval in 2023, Neuralink has since completed human trials, with Elon Musk announcing in 2024 that its first patients are reacting well - a significant step in its ambitious proposals becoming a reality.
The human tests have made the company more appealing to investors, and Neuralink has since raised considerable funds towards advancing its research. It should be noted, though, that despite this positive attention, much discussion surrounding the company regards its animal testing practices, which - some sources say - may have resulted in more animal deaths than necessary as staff were pressured to push for the FDA approval. Despite the ethical debate surrounding Neuralink's practices, its implants seem to be working at their early stages.
Freddie
Company Specialist at Welcome to the Jungle
